Alpenglow Biosciences Analysis: $24M Raised
What is Alpenglow Biosciences?
Alpenglow Biosciences provides AI-powered 3D tissue imaging that captures whole tissues intact while preserving structure for molecular analysis. The platform enables spatial biology insights through non-destructive imaging and AI-driven analysis of tissue architecture and cellular context. Five of the top 10 pharmaceutical companies use the technology to accelerate drug development and improve therapeutic success.
Location
Seattle, United States
Employees
11-50
Founded
2018
Funding Status
Series A
Product Features & Capabilities
- Aurora 3D Spatial Biology Solution
- 3Di™ HOTLS - 3D Imaging Microscope
- 3Dm™ - Data Management
- 3Dai™ - Image Analysis
- 3D Histology Imaging Services
Use Cases
Quantify immune cell infiltration in tumor microenvironments; Analyze nerve and immune cell structures in skin biopsies; Map cellular networks across multi-field tissue samples; Measure cell populations and distances in intact 3D tissue; Generate ground-truth 3D data for model training; Support 3D RNA imaging in research settings
Other Considerations
Five of the top 10 pharmaceutical companies use the platform; Partnerships with Virdx, Molecular Instruments, and Zeiss; Recognized in 3D Imaging World Cup 2025; Provides ground-truth 3D data for AI model training; Preserves tissue for additional molecular analysis after imaging
See something that needs updating? Suggest edits to this profile.